|
Jul 18
|
European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading
|
|
Jul 15
|
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading
|
|
Jul 14
|
European Equities Traded in the US as ADRs Edge Up in Monday Trading
|
|
Jul 1
|
European Equities Traded in the US as American Depositary Receipts Edge Higher in Tuesday Trading
|
|
Jun 26
|
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading
|
|
Jun 24
|
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
|
|
Jun 23
|
European Equities Traded in the US as American Depositary Receipts Edge Lower in Monday Trading
|
|
Jun 17
|
GENFIT: June 17, 2025 Combined Shareholders Meeting Results
|
|
Apr 29
|
GENFIT Announces Publication of the 2024 Universal Registration Document and the 2024 Annual Report on Form 20-F
|
|
Apr 28
|
GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025
|
|
Feb 27
|
GENFIT Announces Revenues and Cash Position as of December 31, 2024
|
|
Feb 21
|
GENFIT Announces the Preliminary Results of the Repurchase Offer to 2025 OCEANEs holders and the Convening of the 2025 OCEANEs holders’ general meeting
|
|
Oct 10
|
High Growth Tech Stocks in France to Watch October 2024
|
|
Oct 9
|
Exclusive Networks And 2 High Growth Tech Stocks In France
|
|
Sep 24
|
Esker And Two High Growth Tech Stocks In France
|
|
Sep 23
|
GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval
|
|
Jul 26
|
GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis
|
|
Jun 17
|
GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH
|
|
Feb 29
|
GENFIT Announces Revenues and Cash Position as of December 31, 2023
|
|
Jan 15
|
GENFIT Announces 2024 Financial Calendar
|